Noninvasive Eye Infection Treatment Shows Promise
(NewsUSA)
- Those who suffer from eye infections that threaten a person’s vision have a new treatment option that is noninvasive and counters the problem of antibiotic resistance, based on recent research and clinical work.
Many eye infections are caused by multi-drug-resistant strains of bacteria and other pathogens, and standard treatments are limited, according to investigators at the Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine in Florida.
VisiRose, a newly launched, privately-held clinical-stage biotechnology company affiliated with Provectus Biopharmaceuticals (OTCQB: PVCT), is collaborating with Bascom Palmer to commercialize a novel, noninvasive therapy for severe eye infections. The treatment, known as Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT), combines a bioactive synthetic small molecule known as Rose Bengal Sodium with a light-based medical device to help manage eye infections caused by bacteria, fungi, and parasites.
“RB-PDAT represents a consequential solution for patients at risk of vision loss from severe infectious keratitis,” said Dominic Rodrigues, acting CEO of VisiRose. RB-PDAT treatment has been associated with rapid resolution of severe eye infections and improved vision outcomes for patients in clinical studies in the U.S., India, Brazil, and Mexico, according to the company.
“We believe Bascom Palmer’s innovative therapy combines infection-fighting capabilities with vision-preserving benefits, paving the way for a brighter future for those struggling with this challenging condition,” said Rodrigues, who also serves as vice chairman of the board of directors and president of Provectus.
Rose Bengal Sodium, the company’s flagship molecule, has demonstrated effectiveness against multi-drug-resistant Pseudomonas aeruginosa, among other strains, in a laboratory setting. At the Ocular Microbiology and Immunology Group conference in 2023, Bascom Palmer researchers reported that 76% of the first 100 patients treated with RB-PDAT at Bascom Palmer, who had severe eye infections unresponsive to standard treatment,achieved successful vision outcomes, with an average time to resolution of just over 6 months.
In a case series published last year in the medical journal JAMA Ophthalmology of nine adults who experienced severe eye infections caused by contaminated artificial tears, RB-PDAT was effective as an addition to antibiotics and helped improve vision outcomes in two patients who received this new therapy, according to Bascom Palmer researchers: a man in his 40s who came to the emergency department with severe pain and decreased vision in his left eye; and a woman in her 80s with worsening redness and visual loss in her right eye.
“This innovative therapy leverages the power of the versatile rose bengal small molecule to fight infection and offers new hope for preserving vision," Rodrigues said.
RB-PDAT has shown promising results in treating severe eye infections in more than 500 individuals worldwide where standard therapies have failed, according to the company press release. Notably, patients in India and Brazil were treated much earlier with RB-PDAT, receiving the oculat treatment as first-line therapy. “VisiRose has the potential to help fill a critical treatment gap in global eye care, particularly in regions and populations severely impacted by antimicrobial resistance with limited access to medical solutions,” Ed Pershing added, who is chairman of VisiRose’s board of directors and also serves as CEO and chairman of Provectus’s board.
Visit www.visirose.com to learn more.
Image caption: Juan Carlos Navia, M.D. at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, delivering the VisiRose RB PDAT treatment in the clinic.
- Do you crave crispy, tasty tortilla chips, and want a snack that you and your family can feel good about? If so, then you'll be happy to hear about a new chip that is now available that is rich in plant-based protein but keeps the delicious flavor and texture of your favorite restaurant-style tortilla chips.
- Every 2 seconds, someone in the United States needs blood, and a single donation can save lives. Shortages in the nation’s blood supply can happen any time. Donors, especially those who donate regularly, keep our blood supply stable.
- Cada 2 segundos, alguna persona en los Estados Unidos necesita sangre. Una sola donación puede salvar vidas. En cualquier momento se puede presentar escasez en el suministro de sangre del país.
-
- Rural Americans often enjoy unique lifestyle benefits, but many still face significant challenges in accessing reliable internet connectivity. With the conclusion of the Affordable Connectivity Program in June, which had offered government-subsidized discounts to eligible households, those in remote areas are now seeking alternative solutions to stay connected.
- More than 2.3 million workers were
- As the new year approaches, many people will be setting financial resolutions with hopes of improving their financial health – whether it's saving more, paying down debt, or investing wisely. However, despite the best of intensions, new research by financial services firm Edward Jones reveals that a variety of factors often prevent these resolutions from sticking.
- Part of the mission of intelligence communities (ICs) is to alert leaders to the likelihood and implications of events such as imminent acts of military aggression by adversaries, sudden political transitions, or economic crises. Policy makers need as much warning as possible in order to prepare next moves in response to potential disruptions or threats on a global scale.
- Here’s a chance for readers to get a sneak peek into some of the hottest books and new voices being talked about in literary circles this holiday season.